v3.25.2
Consolidated Statements Of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Cash Flows from Operating Activities    
Net income $ 124,250 $ 135,904
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 32,277 31,521
Stock option expense 18,307 17,895
Benefit for deferred income taxes (13,243) (2,420)
Noncash long-term incentive compensation 3,273 12,699
Noncash directors' compensation 1,123 1,282
Amortization of debt issuance costs 160 160
Litigation settlements   (5,750)
Changes in operating assets and liabilities:    
Increase in accounts receivable (13,466) (2,422)
(Increase)/decrease in inventories (955) 1,289
(Increase)/decrease in prepaid expenses (7,232) 1,275
Decrease in accounts payable and other current liabilities (12,449) (19,499)
Change in current income taxes (10,764) (10,776)
Net change in lease assets and liabilities (72) (109)
Decrease/(increase) in other assets 48,426 (15,365)
Increase in other liabilities 1,521 15,730
Other sources 194 652
Net cash provided by operating activities 171,350 162,066
Cash Flows from Investing Activities    
Capital expenditures (29,088) (23,225)
Proceeds from sale of fixed assets 480 2,916
Business combinations, net of cash acquired (225) (92,300)
Other uses (322) (265)
Net cash used by investing activities (29,155) (112,874)
Cash Flows from Financing Activities    
Purchases of treasury stock (76,168) (94,228)
Proceeds from exercise of stock options 27,152 38,594
Dividends paid (14,542) (12,107)
Capital stock surrendered to pay taxes on stock-based compensation (8,484) (5,960)
Change in cash overdrafts payable 309 (15,749)
Other sources/(uses) 1,092 (797)
Net cash used by financing activities (70,641) (90,247)
Increase/(decrease) in Cash and Cash Equivalents 71,554 (41,055)
Cash and cash equivalents at beginning of period 178,350 263,958
Cash and cash equivalents at end of period $ 249,904 $ 222,903